Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$1.88 - $36.45 $2.76 Million - $53.6 Million
-1,469,664 Reduced 50.0%
1,469,665 $3.5 Million
Q4 2020

Feb 12, 2021

BUY
$27.25 - $55.82 $80.1 Million - $164 Million
2,939,329 New
2,939,329 $162 Million

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.26B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Vida Ventures Advisors, LLC Portfolio

Follow Vida Ventures Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vida Ventures Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vida Ventures Advisors, LLC with notifications on news.